8.71
price up icon2.11%   0.18
after-market Handel nachbörslich: 8.75 0.04 +0.46%
loading

Finanzdaten der Novavax Inc-Aktie (NVAX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
64.11%
239.24
666.65 88.31 84.51 415.48
Cost Of Revenue
8.57%
15.32
14.12 36.67 60.62 46.24
Gross Profit
65.69%
223.91
652.54 51.64 23.89 369.24
Operating Expenses
10.35%
122.84
137.03 182.72 157.91 208.24
Benefits Costs and Expenses
10.23%
131.79
146.81 161.89 206.84 250.90
Costs And Expenses
8.58%
138.17
151.14 219.39 218.53 254.49
Depreciation and Amortization
9.32%
7.563
8.34 12.52 12.70 11.13
Operating Income/Loss
80.39%
101.07
515.51 -131.08 -134.02 161.00
Income/Loss From Continuing Operations Before Tax
79.33%
107.45
519.85 -73.58 -122.33 164.59
Income Tax Expense/Benefit
21.17%
0.946
1.20 7.449 -1.032 2.205
Income/Loss From Continuing Operations After Tax
79.46%
106.51
518.65 -81.03 -121.30 162.38
Net Income/Loss
79.46%
106.51
518.65 -81.03 -121.30 162.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.60%
162.02
161.05 2.704 160.05 148.38
Diluted Average Shares
0.23%
177.22
177.62 2.704 160.05 165.85
Basic Earnings Per Share
79.50%
0.66
3.22 -0.52 -0.76 1.09
Diluted Earnings Per Share
78.84%
0.62
2.93 -0.52 -0.76 0.99
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.24
price up icon 1.43%
$86.53
price up icon 0.62%
$28.28
price up icon 0.86%
$96.22
price down icon 0.09%
$144.76
price down icon 0.75%
biotechnology ONC
$334.40
price down icon 2.48%
Kapitalisierung:     |  Volumen (24h):